Protein engineering has emerged as a powerful approach toward the development of novel
therapeutics targeting the MYC/MAX/E-box network, an active driver of> 70% of cancers …

A two-step, biocompatible strategy enables site-specific generation of branched and
macrocyclic peptide–protein conjugates. Surface-exposed cysteines on proteins are …